← Leaderboards
Colleen M Niswender
University Of Washington
$8,322,255
Attributed
$13,549,170
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,549,170 · 16
By mechanism
R01$11,573,673 · 8
R21$1,754,111 · 5
UH2$124,768 · 1
F32$92,052 · 1
R03$4,566 · 1
Top collaborators
- Craig Lindsley11 shared
- P Jeffrey Conn4 shared
- Jonathan A Javitch3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Bertil Hille$16,018,907
- Adam Crain$166,526
- Neil Marc Nathanson$6,274,090
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorBrainMetabotropic Glutamate ReceptorsIn VivoResponsePositive Allosteric ModulatorSynapsesChemosensitizationExhibitsLong-Term PotentiationMediatingGenesIn VitroPharmacologyGlutamatesAgonistRodentSchizophreniaCognitive DeficitsGamma-Aminobutyric AcidPhenotypeDrug KineticsNervous System DisorderKnockout Mice
Grant awards (33)
Impact of Metabotropic Glutamate Receptor Heteromerization on Signaling and Pharmacology$603,392
R01 · FY2025 · NS
Regulation of Signaling by mGluR5$601,066
R01 · FY2025 · MH
Identifying the molecular signatures of mGlu receptor heterodimers$435,875
R21 · FY2025 · MH · contact PI
Regulation of metabotropic glutamate receptor activity by protein/protein interactions$396,250
R01 · FY2025 · MH · contact PI
Metabotropic glutamate receptor 7 as a potential genetic modifier of cognitive deficits in neurofibromatosis$237,399
R21 · FY2025 · NS · contact PI
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders$700,523
R01 · FY2024 · MH · contact PI
Regulation of Signaling by mGluR5$601,065
R01 · FY2024 · MH
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology$585,248
R01 · FY2024 · NS
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders$697,667
R01 · FY2023 · MH · contact PI
Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology$633,256
R01 · FY2023 · NS
Regulation of Signaling by mGluR5$601,065
R01 · FY2023 · MH
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders$694,870
R01 · FY2022 · MH · contact PI
Regulation of Signaling by mGluR5$601,065
R01 · FY2022 · MH
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders$695,079
R01 · FY2021 · MH · contact PI
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders$741,117
R01 · FY2020 · MH · contact PI
Development of a Selective Metabotropic Glutamate Receptor 7 Allosteric Modulator Probe$399,571
R01 · FY2019 · MH · contact PI
Development of an mGlu2/4 heterodimer-selective allosteric modulator$464,524
R01 · FY2018 · MH · contact PI
Development of a Selective Metabotropic Glutamate Receptor 7 Allosteric Modulator Probe$400,356
R01 · FY2018 · MH · contact PI
Molecular and Behavioral Neurobiology of Transcription Factor TCF4$392,500
R01 · FY2018 · MH · contact PI
Development of an mGlu2/4 heterodimer-selective allosteric modulator$516,805
R01 · FY2017 · MH · contact PI
Development of a Selective Metabotropic Glutamate Receptor 7 Allosteric Modulator Probe$400,356
R01 · FY2017 · MH · contact PI
Development of an mGlu2/4 heterodimer-selective allosteric modulator$516,805
R01 · FY2016 · MH · contact PI
Development of VU0652957 for the treatment of Parkinson's disease (PD)$124,768
UH2 · FY2016 · NS · contact PI
Metabotropic Glutamate Receptor Regulation in MeCP2-Related Disorders$235,363
R21 · FY2015 · MH · contact PI
Metabotropic Glutamate Receptor Regulation in MeCP2-Related Disorders$196,113
R21 · FY2014 · MH · contact PI
Metabotropic Glutamate Receptors in the Basal Ganglia$225,809
R21 · FY2013 · NS · contact PI
Metabotropic Glutamate Receptors in the Basal Ganglia$195,000
R21 · FY2012 · NS · contact PI
Metabotropic Glutamate Receptors in Basal Ganglia$331,093
R01 · FY2009 · NS · contact PI
Assay for HTS of Gi/Go-linked GPCRs: mGluR7 as Prot(RMI)$38,344
R21 · FY2007 · NS · contact PI
Assay for HTS of Gi/Go-linked GPCRs: mGluR7 as Prot(RMI)$190,208
R21 · FY2005 · NS
Measurement of GPCR-mediated thallium flux:GIRK (RMI)$4,566
R03 · FY2005 · MH
REG EXPRESSION OF CONSTITUTIVELY ACTIVE PKA$50,116
F32 · FY2002 · DK
REG EXPRESSION OF CONSTITUTIVELY ACTIVE PKA$41,936
F32 · FY2001 · DK